Markets
Crypto-friendly bank Erebor in talks to raise $1.5 bln at $9.5 bln valuation
Erebor, a bank catering to crypto, AI and defense sectors, is seeking $1.5 billion in a funding round valuing it at $9.5 billion. Deposits surged to $4.6 billion in July.
Tango Therapeutics set for earnings test after PRMT5 data rally
Biotech firm Tango Therapeutics faces a critical earnings report following a surge in shares after positive PRMT5 data. Investors weigh risks ahead of the release.
Goldman Sachs to acquire NEOS ETFs for $2.3 billion
Deal expands Goldman’s asset management footprint with strategic purchase of ETF provider NEOS, pending regulatory approvals.
Dell, HPE shares rise as Super Micro revenue outlook tops expectations
Super Micro Computer's upbeat revenue guidance for the quarter ahead lifts shares of peers Dell and HPE in premarket trading.
TSX futures rise ahead of U.S. inflation report
Canadian stock index futures edge higher as investors await key U.S. consumer price data that may influence Federal Reserve policy.
Openlane shares fall on market jitters, volume spikes
Stock slides 8% as broader tech rout deepens; trading volume surges to 10-day high.
FTSE 100 flat as Iran denies ceasefire talks amid Hormuz tensions
London stocks held steady as geopolitical risks in the Strait of Hormuz weighed on investor sentiment despite Iran's denial of ceasefire extension negotiations.
Performance Food Group shares fall on weak outlook
Stock declines after the food distributor lowers full-year guidance, citing softer demand and margin pressures.
Why the Euro’s Next Move Hinges on US Inflation, Not ECB Whispers
The euro-dollar pair is approaching the 1.1680 ceiling, but the real driver will be Thursday’s US CPI — a softer print may reportedly give the euro a lift, while a hotter one may reportedly keep it pinned down.
E.ON reports steady H1 2026 growth as shares slip
German utility E.ON posted steady first-half 2026 earnings growth but saw shares dip on investor caution over energy market volatility.
Leap Therapeutics publishes DeFianCe trial results in journal
Biotech firm Leap Therapeutics reports positive findings from its DeFianCe trial in a peer-reviewed journal, citing potential implications for its pipeline.
Definium’s anxiety drug hits Phase 3 success in trial
Positive Phase 3 trial results for Definium’s experimental anxiety treatment could support regulatory submission and potential market entry.
Sitowise Q2 presentation highlights AI, profitability focus after Sweden exit
Finnish engineering firm Sitowise shifts strategy post-Sweden exit, prioritizing artificial intelligence and profitability in Q2 presentation.
Northern 3 VCT adjusts fee terms with Mercia Fund Management
Investment trust revises fee structure in partnership with its manager, Mercia Fund Management, amid ongoing portfolio adjustments.
Victory Capital Holdings shares hit record $114.10
Stock reaches all-time high as asset manager benefits from strong market conditions and investor demand.
Chicago Atlantic reports Q2 2026 earnings miss despite portfolio strength
Commercial real estate lender posts weaker-than-expected earnings for Q2 2026 but highlights resilient underlying portfolio performance.
Mistras Group posts record Q2 EBITDA on Vision2030 progress
Industrial inspection firm raises full-year outlook after delivering record adjusted EBITDA of $52.3 million, driven by cost efficiencies and demand recovery.
Enviri’s Q2 2026 EBITDA rises 22% as Rail exits de-risk
Enviri reports a 22% year-over-year increase in Q2 2026 adjusted EBITDA, driven by the de-risking of its Rail business exits.
Shipfinex, ADI Chain to tokenize $500M vessel fleet on blockchain
Shipfinex will tokenize a $500 million vessel pipeline of 35 ships via ADI Chain, marking a major expansion of blockchain technology into the maritime sector.
Vestis Q3 2026 revenue per pound rises for first time
The clothing rental firm reports its first increase in revenue per pound, signaling potential margin improvements amid ongoing market challenges.
AGT Foods Q2 2026: Packaged foods sales surge 42%, cash flow jumps
Canadian packaged foods producer AGT Foods reports sharp revenue growth and a 93% rise in free cash flow for Q2 2026, driven by strong demand and operational efficiency.
GIC shares reach 52-week high of $40.71
Singapore’s GIC Ltd. hits a new 52-week peak amid broader market strength. The gain reflects investor confidence in the sovereign wealth fund’s diversified portfolio.
Himalaya Shipping posts strong Q2 2026 profit on rising rates
Dry bulk carrier reports sharp earnings growth as freight rates remain elevated amid tight vessel supply.
Arq Q2 2026 margins jump 520 bps on PFAS product launches
Specialty chemicals firm Arq reported a 520 basis-point margin expansion in Q2 2026, driven by new PFAS product launches and improved operational efficiency.
Xencor shares reach 52-week peak at $21.99
Biotech firm Xencor advances to a new annual high, extending a recent upward trend in equity performance.